As recently demonstrated by us, inhibition of PAI-1 exerts beneficial effects on energy and glucose metabolism; moreover, PAI-1 contributes to the development of inflammation in adipose tissue and explains the mechanism of PAI-1-modulated inflammation in the disordered metabolism in HFD-induced obesity [1]. This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.